Oct 10, 2025, 16:41 PM by User Not Found

Bio-IT World | Researchers from Recursion are further developing their work on protein-ligand docking with a new digital tool: the Boltz-ABFE pipeline. This summer, with researchers from MIT, Recursion researchers released Boltz-2, an updated artificial intelligence model that can predict protein structure and binding affinity.

Oct 10, 2025, 08:06 AM by

Clustermarket, the lab equipment scheduling platform, has today announced it is rebranding to Calira and welcoming non-executive director and investor Edmund Wilson, co-founder and former CEO of Titian Software (now Cenevo), to capitalise on increasing enterprise demand for optimising lab operations.

Oct 10, 2025, 08:06 AM by

Alithea Genomics has announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a novel, extraction-free RNA sequencing library preparation kit built for 3D spheroid models.

Oct 10, 2025, 01:01 AM by User Not Found

Bio-IT World | Over 10,000 rare diseases affect millions worldwide, yet fewer than 5% have treatments. Musician-turned-biotech founder Casey McPherson is rewriting the playbook for rare disease research and drug development, which he discusses in the latest episode of Trends from the Trenches.

Oct 8, 2025, 11:08 AM by

Gifthealth, the patient access solution that unifies the prescription journey from provider to patient, today announced it has now served more than six million patients through its direct-to-patient (DTP) platform.

Oct 8, 2025, 11:08 AM by

Oct 8, 2025, 11:08 AM by

AMP announced the publication of a new simplified, consensus-driven NGS molecular biomarker report designed to support oncologists and other healthcare providers. This report provides clear, practical recommendations to help laboratories present complex molecular profiling data in a format that is both clinically useful and consistent with current guidelines.

Oct 8, 2025, 11:08 AM by

CluePoints, provider of leading statistical and AI-driven software solutions, has achieved dual recognition, winning the Clinical Data Science Implementation Excellence Award at the 2025 SCDM Annual Conference and has been named a finalist in the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 SCRIP Awards.

Oct 7, 2025, 08:23 AM by

Lonza has announced the launch of TheraPEAK® AmpliCell® Cytokines and TheraPEAK® 293-GT® Medium to expand its GMP solutions for cell and gene therapy.

Oct 6, 2025, 09:29 AM by

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as finalists in two categories at the prestigious 2025 SCRIP Awards.

Oct 3, 2025, 07:59 AM by

Oct 3, 2025, 07:59 AM by

Oct 3, 2025, 07:59 AM by

- Insilico published a new study unveiling Target Identification Pro (TargetPro), a superior disease-specific model, and TargetBench 1.0, the first standardized benchmarking framework for target discovery. - TargetPro achieved 71.6% retrieval of known clinical targets, a 2–3x improvement over large language models (LLMs) such as GPT-4o, Grok3, DeepSeek-R1, Claude-Opus-4, BioGPT, and public platforms like Open Targets. - TargetPro’s predicted novel targets demonstrated 95.7% structure availability, 86.5% druggability, and 46% repurposing potential, outperforming competing systems on all measures. - TargetBench’s explainable AI models revealed disease-specific feature importance patterns, emphasizing the value of disease-specific target identification models. - New gold standard approaches improve accuracy, reliability, and transparency in AI-driven drug discovery.

Oct 3, 2025, 07:59 AM by

Expanded partnership positions XenoSTART and Minerva Imaging at the forefront of radiopharmaceuticals — one of the fastest-growing areas in oncology drug development.

Oct 2, 2025, 07:40 AM by

Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the Site-Sponsor Consortium’s first industry deliverable designed to streamline a common bottleneck in clinical trials: the Confidential Disclosure Agreement (CDA).

Oct 2, 2025, 01:01 AM by User Not Found

Bio-IT World | The Pistoia Alliance has launched a new initiative to advance the safe adoption of agentic AI. The initiative sits under the Alliance’s strategic priority to Harness AI to Expedite R&D and alongside its AI/ML Community of Experts, which is actively seeking further funding to continue supporting responsible AI adoption across the industry.

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 08:40 AM by

Quantabio has launched the sparQ Lysis Kit, a flexible solution that delivers high-quality, double-stranded genomic DNA from DBS punches in under 50 minutes.

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 08:40 AM by